Home/Filings/4/0001129240-03-000011
4//SEC Filing

DR DAUGHTON JAMES 4

Accession 0001129240-03-000011

CIK 0000724910other

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 5:19 PM ET

Size

10.6 KB

Accession

0001129240-03-000011

Insider Transaction Report

Form 4
Period: 2003-08-21
DR DAUGHTON JAMES
DirectorChief Technology Officer
Transactions
  • Sale

    Common Stock

    2003-08-22$24.08/sh55,000$1,324,400281,800 total
  • Sale

    Common Stock

    2003-08-25$21.67/sh65,000$1,408,550216,800 total
  • Sale

    Common Stock

    2003-08-21$20.61/sh13,000$267,930336,800 total
Holdings
  • Incentive Stock Option

    Exercise: $0.86From: 2003-01-01Exp: 2005-01-01Common Stock (35,000 underlying)
    35,000
  • Incentive Stock Option

    Exercise: $6.08From: 2001-07-26Exp: 2011-07-26Common Stock (22,600 underlying)
    57,600
Footnotes (2)
  • [F1]Includes shares owned jointly by Dr. Daughton and his spouse.
  • [F2]Vesting in four equal installments with the first installment vesting 07/26/2001.

Issuer

NVE CORP /NEW/

CIK 0000724910

Entity typeother
IncorporatedMN

Related Parties

1
  • filerCIK 0001129240

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 5:19 PM ET
Size
10.6 KB